Good News for MS Diagnosis, Prognosis - Medscape
Oct 7, 2021 · Twenty-five year data show a positive shift towards earlier diagnosis and treatment of multiple sclerosis and improved prognosis over time. ... and written about clinical research …
Diagnosing Multiple Sclerosis: 5 Things to Know - Medscape
May 9, 2024 · 2. MS is a clinical diagnosis. According to the McDonald Criteria used for the diagnosis of relapsing MS, patients must have a clinical event consistent with a demyelinating …
The Neuro-Ophthalmology of Multiple Sclerosis - Page 2
Similar to DON, the prognosis for visual recovery is excellent. ... (DON) is a hallmark feature of multiple sclerosis (MS) and often occurrs as the heralding event of the disease.
Adults With Late-Onset MS at High Risk for Rapid Progression
Mar 15, 2024 · More than one in 10 cases of multiple sclerosis (MS) begin after age 50, with more rapid progression to disability and less exposure to and benefit from disease-modifying …
Multiple Sclerosis and Epstein-Barr Virus: What Do We Know?
Apr 2, 2024 · It's thought to be largely innocuous, but EBV is now implicated as a cause of several types of cancer — including lymphoma and nasopharyngeal tumors — and multiple sclerosis …
Multiple Sclerosis Center of Excellence - Medscape
Jan 30, 2025 · Multiple Sclerosis : Multiple Sclerosis Center of Excellence includes the latest research, cases, quizzes, and peer discussion about multiple sclerosis and related comorbidities.
Stop DMT in Stable Multiple Sclerosis: Yes or No? - Medscape
Jan 24, 2025 · A significant portion of patients with multiple sclerosis (MS) can achieve a stable disease state when treated with modern disease-modifying therapy (DMT), especially when …
Multiple Sclerosis: Latest - Index - Medscape
Jan 16, 2025 · Multiple Sclerosis Highlights From ECTRIMS 2024 Highlights in relapsing-remitting multiple sclerosis from ECTRIMS 2024 include treatment for pediatric-onset MS, safety of …
Myeloma: Can Failed Drugs Work Again? - Medscape
Jan 15, 2025 · In a retrospective study of 315 patients with relapsed/refractory multiple myeloma, retreatment with previously refractory drugs achieved an overall response rate of 56.2% and …
Less Fatigue in Multiple Sclerosis With CBT and Modafinil
Nov 13, 2024 · Fatigue related to multiple sclerosis (MS) was significantly reduced following 12 weeks of treatment with cognitive behavioral therapy (CBT) and modafinil, either alone or in …